Your browser is old and is not supported. Upgrade for better security.
Wefunder logo

BioClonetics Immunotherapeutics

Designing the first cure for HIV through the use of monoclonal antibodies

Last Funded September 2017

$386,766

raised from 588 investors

Highlights

1
We have created a cell line that produces an anti-HIV antibody called Clone 3.
2
We have demonstrated that Clone 3 neutralizes all clades and groups of HIV isolates.
3
We have identified that Clone 3 targets HIV at an immutable site on the HIV virus.
4
We expect to complete animal trials within 18 to 24 months.
5
We are working with several world-class laboratories who will assist us in conducting the next steps of our plan.
6
1.2 million estimated people die from HIV each year.
7
2 million estimated people are infected with HIV each year.

Our Team


Downloads

Overview